(Q38040182)

27 August 2017

title

Biomarkers in pre-eclampsia: a novel approach to early detection of the disease (English)

1 reference

27 August 2017

0 references

0 references

0 references

S Masoura

1

1 reference

27 August 2017

I A Kalogiannidis

2

1 reference

27 August 2017

G Gitas

3

1 reference

27 August 2017

A Goutsioulis

4

1 reference

27 August 2017

E Koiou

5

1 reference

27 August 2017

A Athanasiadis

6

1 reference

27 August 2017

N Vavatsi

7

1 reference

27 August 2017

publication date

1 October 2012

1 reference

Journal of Obstetrics and Gynaecology

27 August 2017

published in

1 reference

27 August 2017

volume

32

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

609-616

1 reference

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Underlying disorders associated with severe early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

A multivariate analysis of risk factors for preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Hyperhomocysteinemia: a risk factor for placental abruption or infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Role of the IGF system in trophoblast invasion and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Endoglin modulates cellular responses to TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Placental Localization of Human Pregnancy—Associated Plasma Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Serum leptin levels and the severity of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Homocysteine and endothelial function in human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Latest advances in understanding preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Role of leptin in pregnancy--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Diagnosis and management of gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Extracellular control of TGFbeta signalling in vascular development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Change in paternity: a risk factor for preeclampsia in multiparas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

Role of leptin in fat regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01443615.2012.709290

10.3109/01443615.2012.709290

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference